Unichem Laboratories Ltd. Plans to Sell Drug Unit to Mylan Inc. for $30 Million

February 15, 2013 |

1 min read

India's Unichem LaboratoriesBSE 1.01 % said on Friday it plans to sell a drug manufacturing plant located in central India to a unit of US-based Mylan for Rs 1.6 billion ($29.7 million).

Mergers & acquisitions Asia Europe

MORE ON THIS TOPIC

Illustration of businessman running back around

Autoimmune disease

Sanofi Taps Dren Again in up to $1.7B Autoimmune Partnership

December 15, 2025

·

1 min read

·

Annalee Armstrong

Rheumatoid arthritis (RA) commonly causes inflammation in the hands, leading to pain, swelling, and stiffness in the joints, particularly the small joints of the fingers and wrists. This inflammation results from the immune system attacking the body's own joint tissues, causing the synovium (lining of the joint) to become inflamed and release chemicals that damage nearby tissues.

Mergers & acquisitions

Sobi Makes $1.5B Gout Play With Arthrosi Acquisition

December 15, 2025

·

2 min read

·

Tristan Manalac

Podcast

Weight Loss Waves, Pazdur’s Exit and FDA Instability, New Neuro Breakthroughs

December 10, 2025

·

1 min read

·

Heather McKenzie

Hand with the ace of Spades playing card. Vintage color engraving stylized drawing. Vector illustration

Mergers & acquisitions

Pfizer Is Not a Done Dealmaker After Metsera Buy, With $6B More To Spend

December 10, 2025

·

1 min read

·

Annalee Armstrong